Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IRADIMED CORP
Report date February 11, 2022 · Filed February 12, 2022
Section 16 reporting ended · disclosed 2020-12-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,710 |
Reported balance
After 2022-02-11 transaction · row 1
1 source rowRow 1 · 2022-02-11 · Sale · Disposed 19,286 · Balance 13,710 F1: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $50.00 to $50.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2019 Filed Dec 7, 2019 01:31 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 719 | $22.28 | $16,019.32 |
DisclosureSEC source: 0000898432-19-001355 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,204 Read SEC document |
| December 04, 2019 Filed Dec 7, 2019 01:31 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001355 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Fin. Officer and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 23:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,715 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000015 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,716 Underlying: Common Stock · 2,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 23:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 662 | $24.46 | $16,192.52 |
DisclosureSEC source: 0000898432-19-000015 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,971 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 23:04 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000015 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:35 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001517 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,834 Underlying: Common Stock · 3,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:35 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 833 | $27.02 | $22,507.66 |
DisclosureSEC source: 0000898432-18-001517 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,918 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:35 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 3,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001517 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:31 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 6,299 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001456 · form4.xml · derivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,299 Underlying: Common Stock · 6,299 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 23:11 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001417 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,856 Underlying: Common Stock · 2,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 23:11 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 719 | $26.78 | $19,254.82 |
DisclosureSEC source: 0000898432-18-001417 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,334 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 23:11 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001417 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 08, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,907 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · derivative · entry 9 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,907 shares Expires 2023-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 96,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 08, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 3,907 | $25.76 | $100,663.46 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 6 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 F3 · price: This transaction was executed in multiple trades at prices ranging from $25.50 to $26.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 08, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 3,907 | $1.48 | $5,782.36 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 5 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,008 Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 66,046 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · derivative · entry 8 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,907 Underlying: Common Stock · 66,046 shares Expires 2023-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 96,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 66,046 | $26.03 | $1,719,078.31 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 4 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 F2 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 66,046 | $1.48 | $97,748.08 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,147 Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionStock Option (Right to Buy) · Derivative | 26,297 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · derivative · entry 7 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,953 Underlying: Common Stock · 26,297 shares Expires 2023-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, representing a right to purchase a total of 96,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | SaleCommon Stock | 26,297 | $26.16 | $687,905.85 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 F1 · price: This transaction was executed in multiple trades at prices ranging from $26.00 to $26.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 22:29 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantCommon Stock | 26,297 | $1.48 | $38,919.56 |
DisclosureSEC source: 0000898432-18-000901 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,398 Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,716 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-000004 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,431 Underlying: Common Stock · 2,716 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2018 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 743 | $15.15 | $11,256.45 |
DisclosureSEC source: 0000898432-18-000004 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,101 Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 00:57 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,716 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-000004 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:15 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 3,416 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-17-001308 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,251 Underlying: Common Stock · 3,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stiock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:15 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 1,116 | $13.10 | $14,619.60 |
DisclosureSEC source: 0000898432-17-001308 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,128 Read SEC document |
| December 14, 2017 Filed Dec 18, 2017 23:15 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 3,416 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-17-001308 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CHIEF FINANCIAL OFFICER & SECR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stiock on a one-for-one basis. Read SEC document |
| December 04, 2017 Filed Dec 7, 2017 00:40 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 11,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-045225 · doc1.xml · derivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,808 Underlying: Common Stock · 11,808 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:53 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionRestricted Stock Units · Derivative | 2,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-001000 · doc1.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,147 Underlying: Common Stock · 2,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:53 UTC | IRADIMED CORP IRMD · Entity 4896 | Tax withholdingCommon Stock | 887 | $12.30 | $10,910.10 |
DisclosureSEC source: 0001140361-17-001000 · doc1.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,828 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:53 UTC | IRADIMED CORP IRMD · Entity 4896 | Exercise / conversionCommon Stock | 2,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-17-001000 · doc1.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2016 Filed Dec 17, 2016 00:56 UTC | IRADIMED CORP IRMD · Entity 4896 | GrantRestricted Stock Units · Derivative | 13,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-16-090127 · doc1.xml · derivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,667 Underlying: Common Stock · 13,667 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.